# Wuhan Institute of Biological Products Co., Ltd.

> biotech company

**Wikidata**: [Q98681645](https://www.wikidata.org/wiki/Q98681645)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Wuhan_Institute_of_Biological_Products)  
**Source**: https://4ort.xyz/entity/wuhan-institute-of-biological-products-co-ltd

## Summary
Wuhan Institute of Biological Products Co., Ltd. is a biotechnology company and research institute located in Wuhan, People's Republic of China. Founded in 1950, it operates as a subsidiary of Sinopharm and focuses on the research and development of biological products. The organization is legally formed as a joint-stock company and is distinct from the Wuhan Institute of Virology.

## Key Facts
*   **Official Name:** Wuhan Institute of Biological Products Co., Ltd.
*   **Aliases:** Wuhan Institute of Biological Products; Wuhan Institute of Biology; 武汉生物制品研究所有限责任公司
*   **Inception Date:** September 1, 1950
*   **Parent Organization:** Sinopharm (China National Pharmaceutical Group)
*   **Location:** Jiangxia District, Wuhan, People's Republic of China
*   **Industry:** Research (Biotechnology)
*   **Legal Form:** Joint-stock company
*   **Entity Type:** Business, enterprise, subsidiary company, and research institute
*   **Website:** http://www.wibp.com.cn/
*   **Ringgold ID:** 155181

## FAQs
### Q: Is the Wuhan Institute of Biological Products the same as the Wuhan Institute of Virology?
A: No. While both are research organizations located in Wuhan, they are distinct entities. The Wuhan Institute of Biological Products is a biotech subsidiary of Sinopharm, whereas the Wuhan Institute of Virology is a different institution.

### Q: Who owns the Wuhan Institute of Biological Products?
A: The institute is a subsidiary company of Sinopharm (China National Pharmaceutical Group). It operates as a joint-stock company.

### Q: When was the institute founded?
A: The Wuhan Institute of Biological Products was founded on September 1, 1950.

### Q: What is the primary function of this organization?
A: It functions as both a business enterprise and a research institute. Its primary field of work is research and development within the biotechnology sector.

## Why It Matters
Wuhan Institute of Biological Products Co., Ltd. serves as a significant entity in the Chinese biotechnology landscape, combining the functions of a commercial enterprise with those of a research institute. Established in 1950, it represents a long-standing institutional history in the region, spanning over seven decades of operation. As a subsidiary of Sinopharm, a major state-owned enterprise, the institute plays a key role in the national pharmaceutical and biological products infrastructure.

The organization is distinct in its classification as a research institute that operates under the legal form of a joint-stock company, bridging the gap between academic research and industrial application. Its location in the Jiangxia District of Wuhan positions it within a major hub for industrial and technological development. Furthermore, the explicit distinction between this institute and other Wuhan-based entities like the Wuhan Institute of Virology is critical for accurate categorization within the global scientific community, clarifying its specific role as a production and development arm of a national pharmaceutical group rather than a purely academic virology center.

## Notable For
*   **Dual Classification:** Distinguished by its status as both a research institute and a business enterprise/subsidiary.
*   **Longevity:** A historical entity in the Chinese biotech sector, established in 1950.
*   **Corporate Structure:** Operating as a joint-stock company under the state-owned Sinopharm group.
*   **Distinction:** Explicitly defined as a separate entity from the Wuhan Institute of Virology and the Wuhan Center for Disease Control and Prevention.

## Body

### Organizational Structure and Ownership
Wuhan Institute of Biological Products Co., Ltd. is formally classified as a joint-stock company. It operates as a subsidiary of Sinopharm (China National Pharmaceutical Group). The organization holds multiple classifications, functioning simultaneously as a business, an enterprise, and a research institute. Its Ringgold identifier is 155181.

### History and Location
The institute was founded on September 1, 1950. Its headquarters are situated in Wuhan, specifically within the Jiangxia District of the People's Republic of China. The organization maintains a website at http://www.wibp.com.cn/, which serves as its primary online portal in the Chinese language.

### Field of Work
The primary industry of the entity is research, with a specific focus on research and development (R&D) in the field of biotechnology. The raw description and Wikidata entries classify the organization as a "biotech company."

### Identity and Disambiguation
The entity is known by several aliases, including "Wuhan Institute of Biological Products," "Wuhan Institute of Biology," and its Chinese name "武汉生物制品研究所有限责任公司." It is critical to note that this organization is explicitly defined as being different from the Wuhan Institute of Virology and the Wuhan Center for Disease Control and Prevention, despite the geographical similarity in names.

## References

1. Aligned ISNI and Ringgold identifiers for institutions